Akoya Biosciences, Inc. (NASDAQ:AKYA) Q3 2022 Earnings Conference Call November 7, 2022 5:00 PM ET

Company Participants

Priyam Shah - Senior Director, Investor Relations

Brian McKelligon - Chief Executive Officer

Joseph Driscoll - Chief Financial Officer

Conference Call Participants

Mason Carrico - Stephens

Mark Massaro - BTIG

Neil Vibhakar - Morgan Stanley

Operator

Good day and thank you for standing by. Welcome to the Akoya Biosciences Third Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] please be advised that today's conference is being recorded.

I'd now like to hand the conference over to your speaker today, Priyam Shah, Head of Investor Relations.

Priyam Shah

Thank you, operator and thank you everyone who is joining us today on this call. I'm Priyam Shah, Head of Investor Relations at Akoya Biosciences.

On the call today, we have Brian McKelligon, Chief Executive Officer; and Joe Driscoll, Chief Financial Officer. Earlier today, Akoya released financial results for the third quarter ended September 30, 2022. A copy of the press release is available on the company's website.

Before we begin, I'd like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained in this call that relate to expectations or predictions of future events, results or performance are forward-looking statements. Actual results may differ materially from those expressed or implied in the forward-looking statements due to a variety of factors. For a list and description of the risks and uncertainties associated with Akoya's business, please refer to the Risk Factors section of our Form 10-K filed with the Securities and Exchange Commission on March 15, 2022. We urge you to consider these factors and you should be aware that these statements should be considered estimates only and are not a guarantee of future performance.

This conference call contains time-sensitive information and is accurate only as of the live broadcast today, November 7, 2022. Akoya disclaims any intention or obligation, except as required by law, to update or revise any financial projections or forward-looking statements, whether because of new information, future events or otherwise.

We would like to inform listeners that Akoya will be participating in the upcoming Stephens NASH 2022 Investment Conference in Nashville. Additionally, we will be participating in the Canaccord MedTech and the Piper Sandler Healthcare Conferences in New York this month. please see our Investor Relations page for dates and webcast information. Lastly, we will be hosting our second Annual Spatial Day Virtual Event on December 15, registration information can be found in our press release today and we hope to see many of you attend.